Abstract Details
|
Suma Shah, MD
(Duke University Medical Center)
PRESENTER |
Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Shah has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Shah has received research support from Biogen. The institution of Dr. Shah has received research support from National MS Society. |
| Anastasie M. Dunn-Pirio, MD (UC San Diego) | Dr. Dunn-Pirio has nothing to disclose. |
| Matthew W. Luedke, MD (Duke University Hospital Dept. of Neurology) | Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aucta Pharmaceuticals. Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Luedke has received personal compensation in the range of $0-$499 for serving as a Consultant for Alphasights . Dr. Luedke has received personal compensation in the range of $0-$499 for serving as a Consultant for Clarivate. Dr. Luedke has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Starnes Davis Florie LLP. Dr. Luedke has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Huff Powell Bailey. The institution of Dr. Luedke has received research support from US NAVY. The institution of Dr. Luedke has received research support from Neurona. The institution of Dr. Luedke has received research support from Xenon. |
| Joel C. Morgenlander, MD, FAAN (Duke University Medical Center) | Dr. Morgenlander has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Duke University. |
| Mark B. Skeen, MD, FAAN | Dr. Skeen has received personal compensation for serving as an employee of VeraSci. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD/Serono. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squib. Dr. Skeen has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD/ Serono. The institution of Dr. Skeen has received research support from National MS Society. Dr. Skeen has received personal compensation in the range of $50,000-$99,999 for serving as a Retiree with US Navy. |
| Christopher P. Eckstein, MD | The institution of Dr. Eckstein has received research support from Biogen. The institution of Dr. Eckstein has received research support from Genzyme. |